Methylation of the claudin 1 promoter is associated with loss of expression in estrogen receptor positive breast cancer.
Ontology highlight
ABSTRACT: Downregulation of the tight junction protein claudin 1 is a frequent event in breast cancer and is associated with recurrence, metastasis, and reduced survival, suggesting a tumor suppressor role for this protein. Tumor suppressor genes are often epigenetically silenced in cancer. Downregulation of claudin 1 via DNA promoter methylation may thus be an important determinant in breast cancer development and progression. To investigate if silencing of claudin 1 has an epigenetic etiology in breast cancer we compared gene expression and methylation data from 217 breast cancer samples and 40 matched normal samples available through the Cancer Genome Atlas (TCGA). Moreover, we analyzed claudin 1 expression and methylation in 26 breast cancer cell lines. We found that methylation of the claudin 1
SUBMITTER: Di Cello F
PROVIDER: S-EPMC3701071 | biostudies-literature | 2013
REPOSITORIES: biostudies-literature
ACCESS DATA